Sept. 3 Company Quick Takes: Mundipharma-Cidara, Roche-Spark, Vascepa

Mundipharma licenses rights to Cidara’s rezafungin
Cidara Therapeutics Inc. (NASDAQ:CDTX) granted Mundipharma International Ltd. (Dublin, Ireland) exclusive rights to develop and commercialize rezafungin

Read the full 223 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE